● Recruiting

Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy

Condition: Breast Cancer · Sponsor: Fujian Medical University Union Hospital

PhasePhase 3

Planned participants722

Who can joinFemale, 18 Years to 75 Years

Healthy volunteersYes

About this study

The aim of this study is to explore the impact of internal mammary nodal irradiation on disease-free survival in high-risk breast cancer patients (ypN+or supra/subclavicular lymph node positive) after neoadjuvant chemotherapy.

This description comes directly from the study's public registry record.

Talk to the study team

Yong Yang, M.S · 18813019084 · dr_yangyong1983@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Fujian Medical University Union Hospital

Fuzhou, Fujian, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06559696